US-based premium pet nutrition brand Nulo has officially entered the United Kingdom market, calling the move an important “milestone”...
Lire la suiteGenfit has announced encouraging preliminary findings from a phase 1b clinical trial evaluating its investigational therapy, GNS561, in combination...
Lire la suiteFinnish biotechnology company NADMED has announced the launch of the NADMED Award 2026, positioning it as a catalyst for...
Lire la suiteTitle21 Health Solutions, a portfolio company specialising in life science regulatory support, has joined the Blood and Cells Advocacy...
Lire la suiteRichmond Sausages is preparing to expand its meat-free portfolio with the launch of a new sub-range, Richmond Veggie Tasty,...
Lire la suiteSobi has entered into an agreement to acquire Arthrosi Therapeutics, a private late-stage biotechnology company focused on developing a...
Lire la suite